Financial News
Pfizer beats quarterly estimates despite Covid product decline, reaffirms modest outlook
Pfizer beats quarterly estimates despite Covid product decline, reaffirms modest outlook
More in Financial News
-
Palantir surges 11% after beating earnings estimates. Here’s what’s happening
The rise comes on the back of months of decline for the stock.Read More
-
PayPal shares sink 15% after forecasting weak 2026 earnings; HP’s Enrique Lores named new CEO
PayPal logged revenue of $8.68 billion for the quarter, missing estimates of $8.80 billion....
-
Pfizer says obesity injection shows promise as monthly treatment in mid-stage trial
The data on Pfizer’s GLP-1 offer early evidence that the injection can be administered...
-
PepsiCo’s drink sales are improving, and it’s planning to cut snack prices
PepsiCo reported fourth-quarter earnings and revenue that topped Wall Street’s estimates.Read More

